A Randomized Phase 3 Interim Response Adapted Trial Comparing Standard Therapy with Immuno-oncology Therapy for Children and Adults with Newly Diagnosed Stage I and II Classic Hodgkin Lymphoma
-
Enrollment
This study is currently enrolling. -
Associated Conditions
-
Research Area
Pediatric Research and Clinical Trials -
Location
-
Principal Investigator
-
Sponsor
Children's Oncology Group
The overall goal of this study is to compare the effects, good and/or bad, of brentuximab vedotin and nivolumab (Bv-NIVO) against standard therapy for people with HL to find out which is better.
Enrollment Form
This study is currently enrolling.